PCA analysis for Study ST003428

(Analysis AN005629 )

Select 2 or more experimental factors for PCA analysis.
GroupCombined factors (this analysis)
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:0.05 uM rotenone
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:0.1 uM rotenone
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM rotenone
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:20 uM rotenone
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:2 uM rotenone
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:40 uM rotenone
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 uM rotenone
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:Control
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:0.05 uM rotenone
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:0.1 uM rotenone
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:1 uM rotenone
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:20 uM rotenone
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:2 uM rotenone
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:40 uM rotenone
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:5 uM rotenone
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:Control
Sample source:NA | Sample Type:Blank | Drug Treatment:NA
Sample source:NA | Sample Type:Medium | Drug Treatment:NA
Sample source:NA | Sample Type:QC | Drug Treatment:NA

OR

Perform PCA on individual factors (all analyses in study)
  logo